Risk Stratification for Cephalosporin-Induced Thrombocytopenia: Development and Validation of a Multidimensional Predictive Model in Older Adults
Open Access
- 1 June 2025
- journal article
- research article
- Published by Taylor & Francis in Risk Management and Healthcare Policy
- Vol. ume 18, 2107-2120
Abstract
Objective: Third-generation cephalosporins, while widely prescribed, carry underquantified thrombocytopenia risks in older adults. This study aimed to develop and validate a clinical prediction model for cephalosporin-associated thrombocytopenia in hospitalized patients aged over 65 years. Methods: A retrospective cohort (2019~2023) initially included 45,779 cephalosporin treated patients. After applying exclusion criteria, 12,917 patients were analyzed. Predictors were selected via LASSO regression, with backward elimination multivariate logistic regression constructing a nomogram. Model performance was assessed using AUC, calibration curves, and decision curve analysis (DCA) in training and testing sets. Results: The final model identified eight predictors: baseline platelet count (PLT), red blood cell count (RBC), presence of tumor, renal insufficiency (RI), liver cirrhosis (LC), meropenem use, use of antifungal drugs (AD), and daily usage frequency (DUF). It demonstrated strong discrimination (training AUC 0.82 [95% CI 0.79– 0.85]; testing AUC 0.80 [0.76– 0.84]) and calibration (Brier score 0.057). DCA confirmed clinical utility across wide risk thresholds. Conclusion: This nomogram tool enables rapid thrombocytopenia risk assessment in elderly patients receiving cephalosporins. Clinically, it guides antibiotic selection by quantifying comorbidity-drug interactions, and improves toxicity monitoring accuracy in complex geriatric cases with polypharmacy.Keywords
This publication has 28 references indexed in Scilit:
- Construction of a clinical prediction model for the diagnosis of immune thrombocytopenia based on clinical laboratory parametersJournal of Cancer Research and Clinical Oncology, 2024
- LASSO-derived model for the prediction of bleeding in aspirin usersScientific Reports, 2024
- The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern ChinaScientific Reports, 2023
- Linezolid induced thrombocytopenia in critically ill patients: Risk factors and development of a machine learning-based prediction modelJournal of Infection and Chemotherapy, 2022
- Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patientsEuropean Journal of Hospital Pharmacy, 2022
- Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infectionBiomedical Journal, 2021
- Meropenem-induced thrombocytopenia: a paediatric caseBMJ Case Reports, 2021
- Population Pharmacokinetic Study of Ceftriaxone in Elderly Patients, Using Cystatin C-Based Estimates of Renal Function To Account for FrailtyAntimicrobial Agents and Chemotherapy, 2020
- Risk Factors for Thrombocytopenia in Adult Chinese Patients Receiving Linezolid TherapyCurrent Therapeutic Research, 2012
- Pharmacokinetics in older personsThe American Journal of Geriatric Pharmacotherapy, 2004